Mountain View, Calif. -- Broncus Technologies, a Mountain View-based medical device company developing products for emphysema and other lung diseases, said on Thursday that it has raised $38 million in its seventh round of funding, led by a $25 million investment from Ares Life Sciences. Previous backers Abingworth, Bio*One/Singapore, Charter Ventures, HBM BioVentures, JAIC America, Menlo Ventures, Pac-Link Ventures, Saints Capital and Sightline Ventures also participated. Broncus is currently testing an implantable device designed to reduce lung hyperinflation and shortness of breath by creating new pathways for trapped air to exit the lungs.
http://www.broncus.com/
http://biz.yahoo.com/iw/081204/0457788.html